Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.

× No keyword cloud information.

31 in total

1. (18F) Fluoro-Dopa: a unique gamma emitting substrate for Dopa decarboxylase.

Authors: G Firnau; E S Garnett; T L Sourkes; K Missala
Journal: Experientia Date: 1975-11-15

2. Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.

Authors: A R Cools; J M Van Rossum
Journal: Psychopharmacologia Date: 1976-02-02

3. Evidence for a dopaminergic dominance in the 4,alpha-dimethyl-m-tyramine-induced hypermotility in mice.

Authors: C Rüdeberg
Journal: Psychopharmacology (Berl) Date: 1978-12-08 Impact factor: 4.530

4. Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.

Authors: P M Howse; W B Matthews
Journal: J Neurol Neurosurg Psychiatry Date: 1973-02 Impact factor: 10.154

Review 5. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors: R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1971 Impact factor: 9.546

6. Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors: U K Rinne; V Sonninen; T Sirtola
Journal: Z Neurol Date: 1972

7. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.

Authors: J Constantinidis; J M Gaillard; F Geissbuhler; R Tissot
Journal: Br J Pharmacol Date: 1971-09 Impact factor: 8.739

8. Influence of pheniramine and chlorpheniramine on apomorphine induced compulsive gnawing in mice.

Authors: N K Dadkar; A N Dohadwalla; B K Bhattacharya
Journal: Psychopharmacology (Berl) Date: 1976-07-09 Impact factor: 4.530

9. Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors: U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal: J Neurol Date: 1975-12-02 Impact factor: 4.849

10. Involvement of catecholamines in Haemophilus influenzae induced decrease of beta-adrenoceptor function.

Authors: A J Schreurs; D H Versteeg; F P Nijkamp
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1982-09 Impact factor: 3.000